RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carlos Jiménez to Drug Screening Assays, Antitumor

This is a "connection" page, showing publications Carlos Jiménez has written about Drug Screening Assays, Antitumor.
  1. Pech-Puch D, Rodr?guez J, Cautain B, Sandoval-Castro CA, Jim?nez C. Cytotoxic Furanoditerpenes from the Sponge Spongia tubulifera Collected in the Mexican Caribbean. Mar Drugs. 2019 Jul 16; 17(7).
    View in: PubMed
    Score: 0.150
  2. Jim?nez C, Ellahioui Y, ?lvarez R, Aramburu L, Riesco A, Gonz?lez M, Vicente A, Dahdouh A, Ibn Mansour A, Jim?nez C, Mart?n D, Sarmiento RG, Medarde M, Caballero E, Pel?ez R. Exploring the size adaptability of the B ring binding zone of the?colchicine site of tubulin with para-nitrogen substituted isocombretastatins. Eur J Med Chem. 2015 Jul 15; 100:210-22.
    View in: PubMed
    Score: 0.113
  3. Llanos GG, Araujo LM, Jim?nez IA, Moujir LM, Rodr?guez J, Jim?nez C, Bazzocchi IL. Structure-based design, synthesis, and biological evaluation of withaferin A-analogues as potent apoptotic inducers. Eur J Med Chem. 2017 Nov 10; 140:52-64.
    View in: PubMed
    Score: 0.033
  4. Rega M, Jim?nez C, Rodr?guez J. 6E-hydroximinosteroid homodimerization by cross-metathesis processes. Steroids. 2007 Oct; 72(11-12):729-35.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support